LeMaitre Vascular financials
$82.89+0.67%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $70.4M | $66.6M | $64.5M | $61.0M | $64.2M | $59.9M | $55.7M | $54.8M | $55.8M | $53.5M | $48.9M | $47.4M |
| Gross profit | $50.8M | $48.4M | $46.2M | $46.0M | $45.0M | $41.4M | $38.6M | $37.2M | $38.5M | $36.7M | $33.3M | $30.8M |
| Gross margin | 72.1% | 72.7% | 71.7% | 75.3% | 70.0% | 69.2% | 69.3% | 67.8% | 68.9% | 68.6% | 68.1% | 65.0% |
| Operating income | $20.4M | $17.8M | $18.8M | $20.3M | $16.1M | $12.6M | $12.9M | $13.1M | $14.4M | $11.9M | $10.2M | $9.2M |
| Net income | $17.1M | $15.7M | $15.6M | $17.4M | $13.8M | $11.0M | $11.2M | $11.1M | $11.8M | $9.9M | $8.5M | $7.5M |
| Net margin | 24.2% | 23.6% | 24.2% | 28.4% | 21.5% | 18.4% | 20.1% | 20.3% | 21.2% | 18.5% | 17.3% | 15.8% |
| Diluted EPS | $0.74 | $0.68 | $0.72 | $0.75 | $0.60 | $0.48 | $0.49 | $0.49 | $0.52 | $0.44 | $0.38 | $0.33 |
| EBITDA | $23.1M | $20.4M | $21.4M | $22.9M | $18.8M | $15.2M | $15.3M | $15.6M | $16.8M | $14.3M | $12.6M | $11.6M |
| Operating cash flow | $16.0M | $15.1M | $23.2M | $28.8M | $20.3M | $9.0M | $15.2M | $14.2M | $9.6M | $5.1M | $10.7M | $11.8M |
| Free cash flow | $13.7M | $12.3M | $21.4M | $26.5M | $18.9M | $7.7M | $13.1M | $12.6M | $7.7M | $3.7M | $9.5M | $10.8M |
| Diluted shares | 24.5M | 23.0M | 21.5M | 24.4M | 22.9M | 22.9M | 23.0M | 22.8M | 22.7M | 22.6M | 22.5M | 22.5M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $26.6M | $26.9M | $28.2M | $25.5M | $27.2M | $25.3M |
| Short-term investments | $349.6M | $340.4M | $330.9M | $317.6M | $292.3M | $277.2M |
| Total debt | $169.1M | $168.9M | $168.6M | $168.4M | $168.2M | $168.0M |
| Total assets | $640.5M | $629.5M | $615.7M | $598.1M | $577.6M | $556.0M |
| Total liabilities | $220.2M | $222.9M | $222.2M | $219.1M | $214.9M | $208.4M |
| Shareholders' equity | $420.3M | $406.6M | $393.5M | $378.9M | $362.7M | $347.6M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology